Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Schuth Alexander O.
Relationship:   COFO and Secretary
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   187,341    

Indirect Shares

  523,749      
Direct Value   $3,883,579    

Indirect Value

  $10,857,317      
Total Shares   711,090      
Total Value   $14,740,896      


Denali Therapeutics Inc.
 $3,883,579 Denali Therapeutics Inc.
 $3,883,579
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    15    

     Stock price went up :

    0   
    2    
     Stock price went down :
    0   
    13    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -30.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Denali Therapeutics Inc. DNLI COFO and Secretary 2024-02-14 187,341 2024-02-14 523,749    Premium*  
* Premium Members only  

Records found :    90         Free Registration Required For Full Results.    Limit: 25

Download
  Page 4 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-04-13 4 AS $25.04 $122,646 I/I (4,898) 528,691 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-05-15 4 OE $5.28 $52,800 I/I 10,000 538,691 0 -
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-05-15 4 AS $28.55 $286,044 I/I (10,000) 528,691 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-07-17 4 AS $29.60 $296,000 I/I (10,000) 528,691 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-07-17 4 OE $5.28 $52,800 I/I 10,000 538,691 0 -
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-07-18 4 AS $30.01 $291,157 I/I (9,702) 518,989 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-08-10 4 S $24.18 $68,986 I/I (2,853) 521,761 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-08-14 4 AS $23.67 $65,613 I/I (2,772) 518,989 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-08-21 4 S $22.59 $55,978 I/I (2,478) 521,511 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-08-23 4 AS $23.17 $58,435 I/I (2,522) 518,989 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2024-01-03 4 A $0.00 $0 D/D 53,720 170,157 0 -
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2024-01-05 4 S $19.43 $193,756 I/I (9,972) 539,307 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2024-02-08 4 OE $0.68 $34,000 D/D 50,000 210,185 0 -
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2024-02-13 4 AS $17.29 $46,960 D/D (2,716) 207,469 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2024-02-14 4 AS $17.66 $355,460 D/D (20,128) 187,341 0 %

  90  Records found
  1   2   3   4     
  Page 4 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed